Overexpression of Bax induces apoptosis and enhances drug sensitivity of hepatocellular cancer-9204 cells

World Journal of Gastroenterology

Volumn 11, Issue 23, 2005, Pages 3498-3503

  Zheng, Jian Yong ^a   Yang, Guang Shun ^a   Wang, Wei Zhong ^b   Li, Jiang ^c   Li, Kai Zong ^b   Guan, Wen Xian ^b   Wang, Wen Liang ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bax; Hepatocellular carcinoma

Indexed keywords

COMPLEMENTARY DNA; DOXORUBICIN; LIPOFECTAMINE; PROTEIN BAX; TETRAZOLIUM BLUE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CANCER; NICK END LABELING; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 21344440528     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i23.3498     Document Type: Article

References (30)

1. Salah-Eldin AE Inoue S, Tsukamoto S, Aoi H, Tsuda M. An association of Bcl-2 phosphorylation and Bax localization with their functions after hyperthermia and paclitaxel treatment. Int J Cancer 2003; 103: 53-60
2. Brown JM Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59: 1391-1399
3. Domen J Weissman IL. Hematopoietic stem cells and other hematopoietic cells show broad resistance to chemotherapeutic agents in vivo when overexpressing bcl-2. Exp Hematol 2003; 31: 631-639
4. Kobayashi T Ruan S, Clodi K, Kliche KO, Shiku H, Andreeff M, Zhang W. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents. Oncogene 1998; 16: 1587-1591
5. Guo B Cao S, Toth K, Azrak RG, Rustum YM. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma. Clin Cancer Res 2000; 6: 718-724
6. Zhao Y Xiao B, Chen B, Qiao T, Fan D. Upregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by bax gene transduction. Chin Med J 2000; 113: 977-980
7. Cory S Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22: 8590-8607
8. Kobayashi T Sawa H, Morikawa J, Zhang W, Sawa H. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells. Jpn J Cancer Res 2000; 91: 1264-1268
9. Enari M Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50
10. Sakahira H Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998; 391: 96-99
11. Khwaja A Tatton L. Caspase-mediated proteolysis and activation of protein kinase C plays a central role in neutrophil apoptosis. Blood 1999; 94: 291-301
12. Raisova M Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 2001; 117: 333-340
13. Cory S Adams JM. The Bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2: 647-656
14. Kroemer G Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-519
15. Kirkin V Joos S, Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 2004; 1644: 229-249
16. Beerheide W Tan YJ, Teng E, Ting AE, Jedpiyawongse A, Srivatanakul P. Downregulation of proapoptotic proteins Bax and Bcl-X(S) in p53 overexpressing hepatocellular carcinomas. Biochem Biophys Res Commun 2000; 273: 54-61
17. Thomas A Pepper C, Hoy T, Bentley P. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients. Leuk Res 2000; 24: 813-821
18. Zhang L Yu J, Park BH, Kinzler KW, Vogelstein B. Role of Bax in the apoptotic response to anticancer agents. Science 2000; 290: 989-992
19. Ionov Y Yamamoto H, Krajewski S, Reed JC, Perucho M. Mutational inactivation of the proapoptotic gned BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci USA 2000; 97: 10872-10877
20. Garcia EJ Lawson D, Cotsonis G, Cohen C. Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance. Appl Immunohistochem Mol Morphol 2002; 10: 210-217
21. Ravi R Bedi A. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Cancer Res 2002; 62: 1583-1587
22. LeBlanc H Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002; 8: 274-281
23. Panaretakis T Pokrovskaja K, Shoshan MC, Grander D. Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin. J Biol Chem 2002; 46: 44317-44326
24. Eischen CM Rehg JE, Korsmeyer SJ, Cleveland JL. Loss of Bax alters tumor numbers in ARF-deficient mice. Cancer Res 2002; 62: 2184-2191
25. Eischen CM Roussel MF, Korsmeyer SJ, Cleveland JL. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutation during Myc-mediated lymphomagenesis. Mol Cell Biol 2001; 21: 7653-7662
26. Gamen S Anel A, Perez-Galan P, Lasierra P, Johnson D, Pineiro A, Naval J. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat ceils. Exp Cell Res 2000; 258: 223-235
27. Jurgesmeier JM Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 4997-5002
28. Gao CF Ren S, Zhang L, Nakajima T, Ichinose S, Hara T, Koike K, Tsuchida N. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis. Exp Cell Res 2001; 265: 145-151
29. Dewson G Snowden RT, Almond JB, Dyer MJ, Cohen GM. Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lympocytic leukemia. Oncogene 2003; 22: 2643-2654
30. Lam V McPherson JP, Salmena L, Lees J, Chu W, Sexsmith E, Hedley DW, Freedman MH, Reed JC, Malkin D, Goldenberg GJ. p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin. Leuk Res 1999; 23: 871-880